Article
Synthetic and natural consensus design for engineering charge within an affibody targeting epidermal growth factor receptor.
Biotechnology and bioengineering - 1 Aug 2016
Case Brett A, Hackel Benjamin J
Abstract excerpt
Protein ligand charge can impact physiological delivery with charge reduction often benefiting performance. Yet neutralizing mutations can be detrimental to protein function. Herein, three approaches are evaluated to introduce charged-to-neutral mutations of three cations and three anions within an affibody engineered to bind epidermal growth factor receptor. These approaches-combinatorial library sorting or...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
